New York, New York-- (Newsfile Corp. - February 15, 2025) - Leading securities law firm Bleichmar Fonti & Auld LLP announces that a lawsuit has been filed against ICON plc (NASDAQ: ICLR) and certain ...

If you purchased or acquired securities in ICON between July 27, 2023 and October 23, 2024 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at ...

The Janus Henderson Global Sustainable Equity Fund returned -5.88% for Q4 2024. Click here to read the full commentary.

Headquartered in Dublin, Ireland, ICON Public Limited Company (NASDAQ:ICLR ... is facing headwinds due to tighter management ...

The Janus Henderson Global Sustainable Equity Managed Account Portfolio returned -5.71% (gross) for Q4 2024. Click here to ...

Glancy Prongay & Murray LLP reminds investors of the upcoming April 11, 2025 deadline to file a lead plaintiff motion in the class action filed on behalf of investors who purchased or otherwise ...

Erica Denhoff / Icon ... the biotech firm announced that the U.S. government has awarded it more than a half a billion dollars to develop a vaccine that can be used against bird flu. The company ...

ICON plc, (NASDAQ: ICLR) a world-leading healthcare intelligence and clinical research organisation, today announced that it will release financial results for the fourth quarter and full year 2024 ...

The Law Offices of Frank R. Cruz announces that a class action lawsuit has been filed on behalf of investors who purchased ICON plc ("ICON" or the "Company") (NASDAQ: ICLR) ordinary shares between ...

Headquartered in Dublin, Ireland, ICON Public Limited Company (NASDAQ ... tighter management of R&D spend by pharmaceuticals, less biotechnology funding availability, a greater number of project ...